The record
| Class | bioregulator |
|---|---|
| Also known as | AEDL, Ala-Glu-Asp-Leu, bronchial tetrapeptide |
| Chain length | 4 residues |
| Molecular weight | 446.46 Da |
| Half-life | - |
| Route | SC / oral (class) |
| Studied for | - |
| Research use | - |
| What has been shown | - |
| How it works | Khavinson tetrapeptide for respiratory epithelium (US 7625870); reported to regulate NKX2-1, SCGB1A1, SCGB3A2, FOXA1, FOXA2 expression in bronchial epithelial cells. |
| Patent status | - |
| Regulatory status | - |
Blank = not established in the record. Nothing is estimated to fill a gap.
Where it is matched
- GI Barrier / Gut Integrity (affection, 31%)
- Duchenne muscular dystrophy (illness, 30%)
- Neuromuscular diseases (illness, 30%)
- Muscle loss or weakness (symptom, 33%)